Viewing StudyNCT01462175



Ignite Creation Date: 2024-05-05 @ 11:59 PM
Last Modification Date: 2024-10-26 @ 10:42 AM
Study NCT ID: NCT01462175
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2011-10-27

Brief Title: A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia
Sponsor:
Organization: Hoffmann-La Roche

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 99
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: